Cardiovascular complications of chimeric antigen receptor (CAR)-T cell therapy

27 August 2023 (16:15 - 17:00)

Organised by:

Video

Sign in for access options

Abstract

Slides

About the speaker

Associate Professor Federico Guerra

Marche Polytechnic University of Ancona, Ancona (Italy)

7 More presentations in this session

Presentation thumbnail

Atrial and ventricular arrhythmias with immune checkpoint inhibitor therapy in patients without evidence of myocarditis

Doctor J. Heemelaar (Leiderdorp, NL)

Abstract Slides Video

Presentation thumbnail

Arterial inflammation induced by immune checkpoint inhibitors assessed on 18F-FDG PET-CT scans in stage III/IV melanoma patients

Miss E. Polomski (Leiden, NL)

Abstract Slides Video

Presentation thumbnail

Immune checkpoint inhibitors and atherosclerotic cardiovascular events: a retrospective cohort study

Doctor S. Tan (Melbourne, AU)

Abstract Slides Video

Presentation thumbnail

Gender differences in cardio-oncology care of patients treated with immune checkpoint inhibitor therapy

Associate Professor R. Mincu (Essen, DE)

Abstract Slides Video

Presentation thumbnail

Anti CTLA-4 and PD-1 monoclonal antibodies increases systemic SDF-1 and galectin-3 levels and reduces myocardial strain through NLRP3 and MyD-88 pathways

Doctor N. Maurea (Naples, IT)

Abstract Slides Video

Access the full session

Session thumbnail

T-cells, checkpoint inhibitors, and cardiac complications

The Event

Event poster

ESC Congress 2023

27 August 2023 16:15 CET

You may be interested in

Congress Presentation

Patients with non-Hodgkin's lymphoma treated with CAR T-cell therapy are at risk of impaired left ventricular function

Congress Presentation

Cardiovascular implications of CAR-T cell therapy: insights from a regional cardio-oncology program

Congress Presentation

In vivo CAR-T cells in heart failure

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources